Lexaria Highlights VIRAL-A20-3 STudy Results Showing ‘Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side Effects’
Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side Effects
KELOWNA, BC / ACCESSWIRE / July 21, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or